Gerresheimer AG has initiated the sale of its wholly owned subsidiary Centor Inc., which specializes in packaging systems for dispensing prescription drugs in the USA. The company aims to complete the transaction before the end of the year and has appointed Morgan Stanley & Co. International plc to manage the process. Gerresheimer is also continuing efforts to separate its Moulded Glass business, though the sale process for this unit is not expected to begin in the 2026 financial year but at a later date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gerresheimer AG published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: adhoc_2274486_en), on February 10, 2026, and is solely responsible for the information contained therein.